Emmessar Biotech Nutrition Ltd vs Shreyas Intermediates Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 20, 2026

Key Highlights

The Latest Trading Price of Emmessar Biotech & Nutrition Ltd is ₹ 25 as of 18 Mar 15:30 . The P/E Ratio of Emmessar Biotech & Nutrition Ltd changed from 5.1 on March 2021 to 48.2 on March 2025 . This represents a CAGR of 56.71% over 5 yearsThe P/E Ratio of Shreyas Intermediates Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Emmessar Biotech & Nutrition Ltd changed from ₹ 7.35 crore on March 2021 to ₹ 15.2 crore on March 2025 . This represents a CAGR of 15.64% over 5 yearsThe Market Cap of Shreyas Intermediates Ltd changed from ₹ 35.43 crore on March 2021 to ₹ 58.67 crore on March 2025 . This represents a CAGR of 10.61% over 5 years The revenue of Emmessar Biotech & Nutrition Ltd for the Dec '25 is ₹ 0.58 crore as compare to the Sep '25 revenue of ₹ 0.63 crore. This represent the decline of -7.94% The revenue of Shreyas Intermediates Ltd for the Dec '25 is ₹ 0.12 crore as compare to the Sep '25 revenue of ₹ 10.49 crore. This represent the decline of -98.86% The ebitda of Emmessar Biotech & Nutrition Ltd for the Dec '25 is ₹ 0.15 crore as compare to the Sep '25 ebitda of ₹ 0.17 crore. This represent the decline of -11.76% The ebitda of Shreyas Intermediates Ltd for the Dec '25 is ₹ 0.04 crore as compare to the Sep '25 ebitda of ₹ 0.19 crore. This represent the decline of -78.95% The net profit of Emmessar Biotech & Nutrition Ltd changed from ₹ 0.09 crore to ₹ 0.12 crore over 7 quarters. This represents a CAGR of 17.87% The net profit of Shreyas Intermediates Ltd changed from ₹ -0.4 crore to ₹ -0.39 crore over 7 quarters. This represents a CAGR of -1.44% The Dividend Payout of Emmessar Biotech & Nutrition Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Shreyas Intermediates Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Emmessar Biotech & Nutrition Ltd

Emmessar Biotech & Nutrition Limited (EBNL), originally established on 17th March 1992 as Emmessar Chemical Industries Ltd (ECIL) started its operations in manufacturing Super Specialty Fine Chemicals.
The Company has so far, succeeded in developing many Specialty Fine Chemicals.
ECIL gained official recognition for its R&D from DSIR, Ministry of Science & Technology, Government of India, New-Delhi in early 1996.
To better represent its new core activity, a change in the Company name from Emmessar Chemical Industries Ltd (ECIL) to Emmessar Biotech & Nutrition Ltd (EBNL) on April 7, 2000, was made essential. On realizing that some of the specialty chemicals developed & exported to USA & Europe was being used in producing healthcare formulations, the Company plunged into a new venture in the Healthcare business, where phenomenal growth in the coming decades was anticipated.

About Shreyas Intermediates Ltd

Shreyas Intermediates Limited (SIL) was incorporated as a Private Limited Company on November 6, 1989 and subsequently converted into a Public Limited Company in April, 1992.
The Company was promoted by Dinesh S Sharma.
The Company is engaged in manufacturing of Dyes, Pigments and Pigment Intermediates. In Dec.'93, the company came out with its initial public offering, aggregating Rs 3.29 Cr, to diversify into the manufacture of Copper Phthalocyanine Blue Crude and Copper Phthalocyanine Green, with a capacity of 540 TPA and 321 TPA respectively.
The estimated cost of the project was Rs 8.60 Cr.
Both the products have good export potential especially in the US and Germany. The products of SIL find application in the manufacture of plastic colours, direct colours, inks, rubber paints and in the paint industry.

FAQs for the comparison of Emmessar Biotech & Nutrition Ltd and Shreyas Intermediates Ltd

Which company has a larger market capitalization, Emmessar Biotech & Nutrition Ltd or Shreyas Intermediates Ltd?

Market cap of Emmessar Biotech & Nutrition Ltd is 12 Cr while Market cap of Shreyas Intermediates Ltd is 44 Cr

What are the key factors driving the stock performance of Emmessar Biotech & Nutrition Ltd and Shreyas Intermediates Ltd?

The stock performance of Emmessar Biotech & Nutrition Ltd and Shreyas Intermediates Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Emmessar Biotech & Nutrition Ltd and Shreyas Intermediates Ltd?

As of March 20, 2026, the Emmessar Biotech & Nutrition Ltd stock price is INR ₹25.0. On the other hand, Shreyas Intermediates Ltd stock price is INR ₹6.33.

How do dividend payouts of Emmessar Biotech & Nutrition Ltd and Shreyas Intermediates Ltd compare?

To compare the dividend payouts of Emmessar Biotech & Nutrition Ltd and Shreyas Intermediates Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.